{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:15:15Z","timestamp":1778278515329,"version":"3.51.4"},"reference-count":99,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,20]],"date-time":"2013-07-20T00:00:00Z","timestamp":1374278400000},"content-version":"vor","delay-in-days":1327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.acvd.2009.07.002","type":"journal-article","created":{"date-parts":[[2009,11,20]],"date-time":"2009-11-20T11:01:34Z","timestamp":1258714894000},"page":"847-854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["The controversial role of B-vitamins in cardiovascular risk: An update"],"prefix":"10.1016","volume":"102","author":[{"given":"George","family":"Ntaios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Savopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Grekas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos","family":"Hatzitolios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2009.07.002_bib1","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am J Pathol"},{"key":"10.1016\/j.acvd.2009.07.002_bib2","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","author":"Homocysteine","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2009.07.002_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0021-9150(94)90078-7","article-title":"Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study","volume":"106","author":"Alfthan","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.acvd.2009.07.002_bib4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/ije\/24.4.704","article-title":"Serum total homocysteine and coronary heart disease","volume":"24","author":"Arnesen","year":"1995","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.acvd.2009.07.002_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archinte.159.1.38","article-title":"Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study","volume":"159","author":"Bots","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.acvd.2009.07.002_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(99)93019-2","article-title":"Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men","volume":"355","author":"Chambers","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2009.07.002_bib7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.STR.21.4.572","article-title":"Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke","volume":"21","author":"Coull","year":"1990","journal-title":"Stroke"},{"key":"10.1016\/j.acvd.2009.07.002_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.CIR.98.3.204","article-title":"Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B-vitamins: the Atherosclerosis Risk in Communities (ARIC) study","volume":"98","author":"Folsom","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2009.07.002_bib9","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0735-1097(90)90542-W","article-title":"Plasma homocyst(e)ine levels in men with premature coronary artery disease","volume":"16","author":"Genest","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2009.07.002_bib10","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","article-title":"Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project","volume":"277","author":"Graham","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2009.07.002_bib11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1161\/01.STR.26.5.795","article-title":"Plasma homocysteine in the acute and convalescent phases after stroke","volume":"26","author":"Lindgren","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.acvd.2009.07.002_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0021-9150(96)05890-X","article-title":"Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease","volume":"126","author":"Malinow","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.acvd.2009.07.002_bib13","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/ajcn\/59.4.940","article-title":"Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease","volume":"59","author":"Pancharuniti","year":"1994","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.acvd.2009.07.002_bib14","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0140-6736(95)92407-8","article-title":"Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men","volume":"346","author":"Perry","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2009.07.002_bib15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.CIR.96.2.412","article-title":"Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene","volume":"96","author":"Schwartz","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2009.07.002_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0021-9150(97)00122-6","article-title":"Gender differences and other determinants of the rise in plasma homocysteine after L-methionine loading","volume":"133","author":"Silberberg","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.acvd.2009.07.002_bib17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","article-title":"A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians","volume":"268","author":"Stampfer","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2009.07.002_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0021-9150(98)00139-7","article-title":"Homocysteine and ischaemic heart disease in the Caerphilly cohort","volume":"140","author":"Ubbink","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.acvd.2009.07.002_bib19","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1161\/01.STR.25.10.1924","article-title":"A prospective study of plasma homocyst(e)ine and risk of ischemic stroke","volume":"25","author":"Verhoef","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.acvd.2009.07.002_bib20","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archinte.158.8.862","article-title":"Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention","volume":"158","author":"Wald","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.acvd.2009.07.002_bib21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/hrt.82.4.448","article-title":"Serum total homocysteine and coronary heart disease: prospective study in middle-aged men","volume":"82","author":"Whincup","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2009.07.002_bib22","series-title":"Effects of single and combined B-vitamin supplementation on homocysteine concentrations in different population groups [dissertation] Bonn","author":"Bronstrup","year":"1998"},{"key":"10.1016\/j.acvd.2009.07.002_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/ajcn\/69.1.99","article-title":"Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial","volume":"69","author":"Brouwer","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.acvd.2009.07.002_bib24","first-page":"3","article-title":"Plasma homocysteine response to folate intervention in young women","volume":"164","author":"Cuskelly","year":"1995","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.acvd.2009.07.002_bib25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.ATV.18.3.356","article-title":"Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers","volume":"18","author":"den Heijer","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.acvd.2009.07.002_bib26","series-title":"Vitamin requirements for the reduction of homocysteine blood levels in healthy young women [dissertation] Bonn","author":"Dierkes","year":"1995"},{"key":"10.1016\/j.acvd.2009.07.002_bib27","first-page":"98","article-title":"Folic acid and Vitamin B6 supplementation and plasma homocysteine concentrations in healthy young women","volume":"68","author":"Dierkes","year":"1998","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.acvd.2009.07.002_bib28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2796.1995.tb01190.x","article-title":"Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid","volume":"237","author":"Landgren","year":"1995","journal-title":"J Intern Med"},{"key":"10.1016\/j.acvd.2009.07.002_bib29","first-page":"195","article-title":"A pilot study with simvastatin and folic acid\/vitamin B12 in preparation for the study of the effectiveness of additional reductions in cholesterol and homocysteine (Search)","volume":"10","author":"MacMahon","year":"2000","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2009.07.002_bib30","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJM199804093381501","article-title":"Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease","volume":"338","author":"Malinow","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2009.07.002_bib31","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/01.ATV.17.6.1157","article-title":"The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes","volume":"17","author":"Malinow","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.acvd.2009.07.002_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(95)92113-3","article-title":"Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations","volume":"346","author":"Naurath","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2009.07.002_bib33","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1053\/euhj.2002.3161","article-title":"Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease","volume":"23","author":"Neal","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2009.07.002_bib34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.nrl.0000253066.85963.aa","article-title":"Vitamins and stroke: the homocysteine hypothesis still in doubt","volume":"14","author":"Ntaios","year":"2008","journal-title":"Neurologist"},{"key":"10.1016\/j.acvd.2009.07.002_bib35","first-page":"172A","article-title":"B-vitamin supplementation lowers homocysteine levels in heart disease","volume":"42","author":"Saltzman","year":"1994","journal-title":"Clin Res"},{"key":"10.1016\/j.acvd.2009.07.002_bib36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.ejcn.1600576","article-title":"The responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study","volume":"52","author":"Schorah","year":"1998","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.acvd.2009.07.002_bib37","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/S0735-1097(01)01235-9","article-title":"A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease","volume":"37","author":"Thambyrajah","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2009.07.002_bib38","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.CIR.102.8.871","article-title":"Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?","volume":"102","author":"Thambyrajah","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2009.07.002_bib39","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/BF00180030","article-title":"Hyperhomocysteinemia and the response to vitamin supplementation","volume":"71","author":"Ubbink","year":"1993","journal-title":"Clin Investig"},{"key":"10.1016\/j.acvd.2009.07.002_bib40","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/jn\/124.10.1927","article-title":"Vitamin requirements for the treatment of hyperhomocysteinemia in humans","volume":"124","author":"Ubbink","year":"1994","journal-title":"J Nutr"},{"key":"10.1016\/j.acvd.2009.07.002_bib41","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/ajcn\/77.5.1318","article-title":"Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study","volume":"77","author":"van Oort","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.acvd.2009.07.002_bib42","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/archinte.161.5.695","article-title":"Randomized trial of folic acid supplementation and serum homocysteine levels","volume":"161","author":"Wald","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.acvd.2009.07.002_bib43","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/ajcn\/67.5.858","article-title":"Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind, randomized, factorial-design, controlled trial","volume":"67","author":"Woodside","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.acvd.2009.07.002_bib44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-2000-8101","article-title":"Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements","volume":"26","author":"Clarke","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.acvd.2009.07.002_bib45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-135-2-200107170-00014","article-title":"Power shortage: clinical trials testing the \u201chomocysteine hypothesis\u201d against a background of folic acid-fortified cereal grain flour","volume":"135","author":"Bostom","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acvd.2009.07.002_bib46","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/JAD-2006-9408","article-title":"Homocysteine metabolism and various consequences of folate deficiency","volume":"9","author":"Tchantchou","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.acvd.2009.07.002_bib47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.acvd.2009.07.002_bib48","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM198509193131201","article-title":"Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease","volume":"313","author":"Boers","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2009.07.002_bib49","first-page":"1","article-title":"The natural history of homocystinuria due to cystathionine beta-synthase deficiency","volume":"37","author":"Mudd","year":"1985","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.acvd.2009.07.002_bib50","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/qjmed\/90.8.511","article-title":"Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease","volume":"90","author":"van der Put","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.acvd.2009.07.002_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0021-9150(92)90246-D","article-title":"Age dependency of cystathionine beta-synthase activity in human fibroblasts in homocyst(e)inemia and atherosclerotic vascular disease","volume":"94","author":"Nordstrom","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.acvd.2009.07.002_bib52","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2362.1995.tb01687.x","article-title":"Plasma homocysteine and menopausal status","volume":"25","author":"Wouters","year":"1995","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.acvd.2009.07.002_bib53","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/beha.1999.0036","article-title":"Hyperhomocysteinaemia","volume":"12","author":"Perry","year":"1999","journal-title":"Baillieres Best Pract Res Clin Haematol"},{"key":"10.1016\/j.acvd.2009.07.002_bib54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(99)02153-4","article-title":"Serum homocysteine increases after therapy with fenofibrate or bezafibrate","volume":"354","author":"Dierkes","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2009.07.002_bib55","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0955-2863(97)00110-1","article-title":"The effect of L-dopa administration and folate deficiency on plasma homocysteine concentrations in rats","volume":"8","author":"Daly","year":"1997","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.acvd.2009.07.002_bib56","first-page":"S11","article-title":"Homocysteinemia and vascular disease in end-stage renal disease","volume":"57","author":"Dennis","year":"1996","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.acvd.2009.07.002_bib57","doi-asserted-by":"crossref","first-page":"c180","DOI":"10.1159\/000087412","article-title":"Association between hyperhomocysteinemia and ultrasonographic atherosclerotic indices of carotid arteries in chronic hemodialysis patients","volume":"101","author":"Grekas","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.acvd.2009.07.002_bib58","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/clpt.1989.179","article-title":"Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patients receiving low-dose methotrexate treatment","volume":"46","author":"Refsum","year":"1989","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.acvd.2009.07.002_bib59","first-page":"828","article-title":"Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate","volume":"51","author":"Refsum","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.acvd.2009.07.002_bib60","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0002-9343(97)00129-0","article-title":"Homocysteine in sickle cell disease: relationship to stroke","volume":"103","author":"Houston","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.acvd.2009.07.002_bib61","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2141.1999.01340.x","article-title":"Homocysteine levels in polycythaemia vera and essential thrombocythaemia","volume":"105","author":"Gisslinger","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.acvd.2009.07.002_bib62","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2009.07.002_bib63","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.acvd.2009.07.002_bib64","doi-asserted-by":"crossref","unstructured":"Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 2005; 82:806-12.","DOI":"10.1093\/ajcn\/82.4.806"},{"key":"10.1016\/j.acvd.2009.07.002_bib65","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ajcn\/73.3.613","article-title":"Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort","volume":"73","author":"Jacques","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.acvd.2009.07.002_bib66","doi-asserted-by":"crossref","unstructured":"Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J 2006; 151:282-7.","DOI":"10.1016\/j.ahj.2005.04.025"},{"key":"10.1016\/j.acvd.2009.07.002_bib67","first-page":"3642","article-title":"Blinded comparison of folic acid and placebo in patients with ischemic heart disease: an outcome trial [abstract]","volume":"106","author":"Baker","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2009.07.002_bib68","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2009.07.002_bib69","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"Bonaa","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2009.07.002_bib70","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/01.CIR.103.7.919","article-title":"Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE)","volume":"103","author":"Lonn","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2009.07.002_bib71","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2009.07.002_bib72","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jama.300.7.795","article-title":"Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial","volume":"300","author":"Ebbing","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2009.07.002_bib73","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","article-title":"Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial","volume":"299","author":"Albert","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2009.07.002_bib74","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/jama.300.12.1409-a","article-title":"Effect of folic acid and B vitamins on cardiovascular disease in women","volume":"300","author":"Ntaios","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2009.07.002_bib75","first-page":"2673","article-title":"De Luca G, et al","volume":"350","author":"Lange","year":"2004","journal-title":"Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med"},{"key":"10.1016\/j.acvd.2009.07.002_bib76","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/hrt.2004.035030","article-title":"Secondary prevention with folic acid: results of the Goes extension study","volume":"91","author":"Liem","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2009.07.002_bib77","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2003.02.001","article-title":"Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomized pilot trial","volume":"93","author":"Liem","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2009.07.002_bib78","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/oxfordjournals.aje.a008798","article-title":"Lowered risks of hypertension and cerebrovascular disease after vitamin\/mineral supplementation: the Linxian Nutrition Intervention Trial","volume":"143","author":"Mark","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.acvd.2009.07.002_bib79","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000093680","article-title":"Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients","volume":"24","author":"Righetti","year":"2006","journal-title":"Blood Purif"},{"key":"10.1016\/j.acvd.2009.07.002_bib80","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jama.288.8.973","article-title":"Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial","volume":"288","author":"Schnyder","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2009.07.002_bib81","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/01.ASN.0000110181.64655.6C","article-title":"Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease","volume":"15","author":"Wrone","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.acvd.2009.07.002_bib82","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jacc.2005.10.064","article-title":"Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial","volume":"47","author":"Zoungas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2009.07.002_bib83","doi-asserted-by":"crossref","first-page":"373","DOI":"10.5414\/CNP66373","article-title":"Folate supplementation fails to affect vascular function and carotid artery intima-media thickness in cyclosporin A-treated renal transplant recipients","volume":"66","author":"Austen","year":"2006","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.acvd.2009.07.002_bib84","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ijcard.2006.07.031","article-title":"Effect of folic acid treatment on carotid intima-media thickness of patients with coronary disease","volume":"118","author":"Fernandez-Miranda","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2009.07.002_bib85","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/STROKEAHA.108.526798","article-title":"High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial","volume":"40","author":"Hodis","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.acvd.2009.07.002_bib86","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1097\/01.TP.0000058810.59825.58","article-title":"Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients","volume":"75","author":"Marcucci","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.acvd.2009.07.002_bib87","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijcard.2008.03.028","article-title":"Is there a beneficial effect of folic acid on carotid intima-media thickness?","volume":"135","author":"Ntaios","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2009.07.002_bib88","doi-asserted-by":"crossref","unstructured":"Ntaios G, Savopoulos C, Karamitsos D, et al. The effect of folic acid supplementation on carotid intima-media thickness in patients with cardiovascular risk: A randomized, placebo-controlled trial. Int J Cardiol 2009;online early view:doi:10.1016\/j.ijcard.2009.01.023.","DOI":"10.1016\/j.ijcard.2009.01.023"},{"key":"10.1016\/j.acvd.2009.07.002_bib89","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2261-8-24","article-title":"The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis","volume":"8","author":"Potter","year":"2008","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.acvd.2009.07.002_bib90","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.atherosclerosis.2004.12.043","article-title":"Decrease of carotid intima-media thickness in patients at risk to cerebral ischemia after supplementation with folic acid, Vitamins B6 and B12","volume":"181","author":"Till","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.acvd.2009.07.002_bib91","first-page":"1187","article-title":"Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients","volume":"89","author":"Tungkasereerak","year":"2006","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.acvd.2009.07.002_bib92","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.296.22.2720","article-title":"Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials","volume":"296","author":"Bazzano","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2009.07.002_bib93","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(07)60854-X","article-title":"Efficacy of folic acid supplementation in stroke prevention: a meta-analysis","volume":"369","author":"Wang","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2009.07.002_bib94","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCULATIONAHA.105.570846","article-title":"Improvement in stroke mortality in Canada and the United States, 1990 to 2002","volume":"113","author":"Yang","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2009.07.002_bib95","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejim.2008.03.015","article-title":"Well done folate, the little boy was born healthy without spina bifida: but will he suffer a stroke when elderly?","volume":"20","author":"Ntaios","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.acvd.2009.07.002_bib96","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMe068060","article-title":"Homocysteine trials--clear outcomes for complex reasons","volume":"354","author":"Loscalzo","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2009.07.002_bib97","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1161\/01.ATV.0000242801.38419.48","article-title":"Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease","volume":"26","author":"Mittermayer","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.acvd.2009.07.002_bib98","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/eurheartj\/ehn515","article-title":"Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials","volume":"30","author":"Antoniades","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2009.07.002_bib99","first-page":"1575","article-title":"Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis","volume":"45","author":"Clarke","year":"2007","journal-title":"Clin Chem Lab Med"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213609002411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213609002411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:37:27Z","timestamp":1761745047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213609002411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":99,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1875213609002411"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2009.07.002","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The controversial role of B-vitamins in cardiovascular risk: An update","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2009.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}